AJP - GI AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 297: G76-G81, 2009. First published May 21, 2009; doi:10.1152/ajpgi.00053.2009
0193-1857/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/1/G76    most recent
00053.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Liu, S. X. L.
Right arrow Articles by De Plaen, I. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, S. X. L.
Right arrow Articles by De Plaen, I. G.

INFLAMMATION/IMMUNITY/MEDIATORS

Platelet-activating factor induces the processing of nuclear factor-{kappa}B p105 into p50, which mediates acute bowel injury in mice

Shirley X. L. Liu,1 Runlan Tian,1 Heather Baskind,1 Wei Hsueh,2 and Isabelle G. De Plaen1

Departments of 1Pediatrics (Neonatology) and 2Pathology, Children's Memorial Research Center, Northwestern University Feinberg School of Medicine (Medical School), Chicago, Illinois

Submitted 10 February 2009 ; accepted in final form 14 May 2009

Platelet-activating factor (PAF), an endogenous proinflammatory phospholipid, when injected intravascularly to rats and mice, causes shock, acute bowel injury, and a rapid activation of NF-{kappa}B p50-p50 with upregulation of the chemokine CXCL2 in the intestine. In this study, we investigate the mechanism of NF-{kappa}B activation and the role of the NF-{kappa}B p50 subunit in PAF-induced shock and acute bowel injury. NF-{kappa}B p50-deficient mice and wild-type mice were anesthetized and tracheotomized, and their carotid artery was cannulated for blood pressure monitoring, blood sampling, and PAF administration. For determination of bowel injury, shock, and survival, PAF (2.2 µg/kg, intra-arterially, i.a.) was injected. Two hours later, animals were euthanized, and their small intestines were removed for histological examination. For biochemical studies, PAF (1.5 µg/kg i.a.) was administered and the small intestine removed after 15–60 min. We found that PAF induced an increase in p105 processing within 30 min, but there were no changes in the levels of the NF-{kappa}B inhibitory proteins I{kappa}B{alpha} and β. NF-{kappa}B p50-deficient mice were protected against PAF-induced mortality, shock, intestinal hypoperfusion, and injury compared with wild-type animals. We also found that p50-deficient mice had decreased gene expression of CXCL2 and TNF and a decrease in CXCL2 protein production compared with wild-type mice. Our study suggests that PAF increases the processing of NF-{kappa}B p105 into p50, with upregulation of proinflammatory cytokines, which leads to PAF-induced systemic inflammatory response and acute bowel injury.

intestine; necrotizing enterocolitis



Address for reprint requests and other correspondence: I. G. De Plaen, Dept. of Pediatrics, Div. of Neonatology, #45, Children's Memorial Hospital, 2300 Children's Plaza, Chicago, IL 60614, (e-mail: isabelledp{at}northwestern.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.